US 12,285,175 B2
Occlusion device
Stephen Griffin, Fremont, CA (US)
Assigned to Stryker Ireland Technology Ltd., Carrigtwohill (IE)
Filed by Cerus Endovascular Limited, Oxford (GB)
Filed on Apr. 3, 2023, as Appl. No. 18/295,106.
Application 18/295,106 is a continuation of application No. 16/952,756, filed on Nov. 19, 2020, granted, now 11,648,013.
Application 16/952,756 is a continuation of application No. 16/080,626, granted, now 10,869,672, issued on Dec. 22, 2020, previously published as PCT/EP2017/055765, filed on Mar. 13, 2017.
Claims priority of provisional application 62/307,137, filed on Mar. 11, 2016.
Prior Publication US 2023/0240687 A1, Aug. 3, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/12 (2006.01); A61B 90/00 (2016.01); A61B 17/00 (2006.01)
CPC A61B 17/12122 (2013.01) [A61B 17/12172 (2013.01); A61B 17/12177 (2013.01); A61B 90/39 (2016.02); A61B 2017/00243 (2013.01); A61B 2017/00575 (2013.01); A61B 2090/3966 (2016.02)] 20 Claims
OG exemplary drawing
 
1. An occlusion device comprising:
(a) a substantially solid marker band having an inner and outer diameter, a proximal end, and a distal end; and
(b) a resilient mesh body attached within the substantially solid marker band,
wherein the resilient mesh body has a length y,
wherein the occlusion device comprises a bolus of additional resilient mesh material of a length x arranged within the resilient mesh body, wherein y is greater than x,
wherein the resilient mesh body extends distally from the substantially solid marker band,
wherein the resilient mesh body has a first delivery shape and a second expandable deployed shape, and
wherein the second expandable deployed shape is in a shape of an inverted mushroom.